Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and long-term viral suppression among all groups remains a challenge.
Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and long-term viral suppression among all groups remains a challenge.
While adults with HIV are able to achieve nearly 95 per cent viral suppression after receiving antiretroviral therapy (ART), the progress among children and adolescents is lagging, according to a study led by the US National Institutes of Health (NIH).